World Health Assembly guest speakers focus on gender-based violence and newborn health

20 May, 2014

reference: http://www.who.int/mediacentre/news/releases/2014/WHA-20140520/en/

 Dr Christine Kaseba-Sata, First Lady of Zambia (WHO Goodwill Ambassador against gender-based violence) and Melinda Gates, co-Chair of the Bill and Melinda Gates Foundation addressed delegates at the World Health Assembly this afternoon.

Dr Kaseba-Sata deplored the prevalence of violence against women and girls and the extent to which cases of violence remain hidden and unrecognized. A former gynaecologist, she noted the lasting damage such violence can inflict on mental and physical health: “Almost all gender-based violence victims fall on the doorstep of the health sector.”

She stressed that the health sector has a responsibility to address the causes and consequences of violence. She called on delegates to ensure that everyone affected by violence has timely, effective and affordable access to all the health services they require, and that those services are free of abuse, disrespect and discrimination.

Ms Gates then highlighted ways to improve the health of mothers and newborn babies, emphasizing the value of linking efforts to improve reproductive, maternal, newborn and child health – “the continuum of care”.

She pointed out that: “If women can plan their families, they are more likely to space their pregnancies. If they space their pregnancies, they are more likely to have healthy babies. If babies are healthy, they are more likely to flourish as children. When mothers have healthy pregnancies, and when children thrive, the positive benefits last a lifetime.”

She also called on delegates to pay more attention to newborn babies. Although there has been remarkable global progress in reducing the number of children dying before their fifth birthday, neonatal mortality rates have declined at a slower pace.

The Health Assembly will discuss a new action plan for newborns later this week. Ms Gates and other panelists at today’s technical briefing discussed quality of care around childbirth, and its potential to end preventable maternal and newborn deaths and stillbirths, generating a “triple return on investment”.

 

World Health Assembly approves resolution on hepatitis and mechanism to coordinate noncommunicable disease response

22 May, 2014
reference: http://www.who.int/mediacentre/news/releases/2014/WHA-20140522/en/

 The World Health Assembly approved a resolution to improve the prevention, diagnosis and treatment of viral hepatitis and proposals to improve global coordination of efforts to address noncommunicable diseases like diabetes, cancers, heart disease and stroke. In addition, WHO’s Director-General and the President of the Health Assembly presented 4 awards to leaders in public health.

Viral hepatitis

Viral hepatitis is responsible for 1.4 million deaths every year; 500 million people currently live with the disease. There are 5 main hepatitis viruses (A, B, C, D and E). Types B and C lead to chronic disease in hundreds of millions of people and, together, are the most common cause of liver cirrhosis and cancer. The resolution also highlights the importance of expanding hepatitis A and B vaccination programmes and further strengthening infection control measures in health-care settings – such as strategies to improve the safety of injections.

The resolution noted the importance of implementing appropriate measures to protect groups such as people who inject drugs from infection and to improve their access to diagnostics and treatment. As most people with chronic hepatitis B or C remain unaware of their infection, there is also a need to improve screening.

Delegates agreed to consider a range of measures to improve access to quality and affordable hepatitis medicines and diagnostics, whilst addressing intellectual property rights issues related to those products.

The delegates asked the WHO Secretariat to continue to help countries develop robust strategies and goals on hepatitis and to report regularly on the progress of such programmes, as well as examining the feasibility of eliminating hepatitis B and C.

Noncommunicable diseases (NCDs)

Delegates approved 9 indicators to measure progress in implementing the WHO Global NCD Action Plan. They also endorsed the terms of reference and workplan for a Global Coordination Mechanism. The Assembly recommended that the Director-General submit proposed terms of reference for a United Nations Interagency Task Force on NCDs to the United Nations Economic and Social Council (ECOSOC).

A United Nations High-level Meeting will take place in New York on 10–11 July 2014 to review progress on NCDs. Member States asked the WHO Secretariat to report on the follow-up to this meeting at the next Health Assembly.

Awards

Director-General Dr Margaret Chan and the President of the Sixty-seventh World Health Assembly, Dr Roberto Tomas Morales Ojeda, today awarded 4 prizes to leaders in public health.

The Ihsan Dogramaci Family Health Foundation Prize is awarded to Professor Zulfiqar Bhutta (Pakistan) for his global work on child and newborn survival and health.

The Sasakawa Health Prize is awarded to the Leprosy Control Foundation /Dominican Institution of Dermatology and Skin Surgery “Dr Hubert Bogaert Diaz” to expand services for children affected by skin diseases other than leprosy.

The United Arab Emirates Health Foundation Prize was awarded to the Institution for Research in Health (INISA) (Costa Rica) for its work on gastric cancer and occupational exposure to pesticides.

The Dr Lee Jong-wook Memorial Prize for Public Health was awarded jointly to Professor Sinata Koulla-Shiro (Cameroon) and the Czech Society of Cardiology (Czech Republic).

World Health Assembly progress on noncommunicable diseases and traditional medicine

23 May, 2014

reference: http://www.who.int/mediacentre/news/releases/2014/WHA-20140523/en/

 The World Health Assembly continued progress Friday, approving plans to better incorporate palliative care, expand inclusion of the needs of those affected by autism, improve access to health care for those with disabilities, better integrate the use of traditional medicine and raise awareness of psoriasis.

Traditional medicine

The Health Assembly approved WHO’s traditional medicine strategy 2014–2023. Traditional medicine covers a wide variety of therapies and practices which vary from country to country and region to region. The strategy aims to build the knowledge base for national policies and strengthen quality assurance, safety, proper use and effectiveness of traditional and complementary medicine through regulation. It also aims to promote universal health coverage by integrating traditional and complementary medicine services into health care service delivery and home care.

Disability action plan

A new WHO global disability action plan 2014–2021 aims to improve the health and quality of life of the one billion people around the world with disabilities by improving their access to health care and creating new and strengthening existing services and technologies that help them acquire or restore skills and functions. It also aims to strengthen data and research.

People with disabilities have the same general health care needs as others, but are three times more likely to be denied health care and four times more likely to be treated badly in health facilities. One in seven people worldwide has a disability. As people live longer and chronic diseases increase, more people are likely to develop disabilities. Road traffic crashes, falls, violence, natural disasters and conflict, unhealthy diet and substance abuse can also lead to disability.

Autism spectrum disorders

The Health Assembly urged Member States to include the needs of individuals affected by autism spectrum and other developmental disorders in policies and programmes related to child and adolescent health and development and mental health. This means increasing the capacity of health and social care systems to provide services for individuals with autism spectrum disorders and for their families and shifting the focus of care from long-stay health facilities towards non-residential services in the community. It also means improving health surveillance systems to capture data on autism spectrum disorders and ensuring countries are better able to diagnose and treat autism spectrum disorders.

The resolution highlights the need for the WHO Secretariat to help strengthen countries’ capacities to address autism spectrum and other developmental disorders; facilitate resource mobilization; engage with autism-related networks; and monitor progress. All efforts will be conducted in alignment with the WHO Mental health action plan 2013–2020.

Autism spectrum disorders comprise a range of development disorders which include autism, childhood disintegrative disorder and Asperger syndrome. Worldwide, most people with autism spectrum disorders and their families do not receive any care from health and social care systems.

Psoriasis

A resolution on psoriasis encourages Member States to raise awareness about the disease and to advocate against the stigma experienced by so many people who suffer from it. It requests the WHO Secretariat to draw attention to the public health impact of psoriasis and publish a global report on the disease, emphasizing the need for greater research and identifying successful strategies for integrating the management of psoriasis into existing services for noncommunicable diseases by the end of 2015.

Psoriasis is a chronic inflammatory disease characterised by scaly, red skin lesions. People with psoriasis have relatively higher risks of heart disease, stroke, hypertension and diabetes. Studies have documented higher rates of depression and anxiety compared with the general population.

Strengthening palliative care as a component of comprehensive care

Today’s resolution emphasizes that the need for palliative care services will continue to grow – partly because of the rising prevalence of noncommunicable diseases and the ageing of populations everywhere. The WHO global action plan for the prevention and control of noncommunicable diseases 2013–2020, endorsed by the Health Assembly in May 2013, includes palliative care among the policy options proposed to Member States and in its global monitoring framework.

World Health Assembly closes

24 May, 2014

reference: http://www.who.int/mediacentre/news/releases/2014/WHA-20140524/en/

 The Sixty-seventh World Health Assembly closed today, after adopting more than 20 resolutions on public health issues of global importance.

“This has been an intense Health Assembly, with a record-breaking number of agenda items, documents and resolutions, and nearly 3 500 registered delegates,” said Dr Margaret Chan, WHO’s Director-General. “This is a reflection of the growing number of complexity of health issues, and your deep interest in addressing them.”

A number of the Health Assembly resolutions were approved today on the following issues.

Antimicrobial drug resistance

The delegates recognized their growing concern of antimicrobial resistance and urged governments to strengthen national action and international collaboration. This requires sharing information on the extent of resistance and the use of antibiotics in humans and animals. It also involves improving awareness among health providers and the public of the threat posed by resistance, the need for responsible use of antibiotics, and the importance of good hand hygiene and other measures to prevent infections.

The resolution urges Member States to strengthen drug management systems, to support research to extend the lifespan of existing drugs, and to encourage the development of new diagnostics and treatment options.

As requested in the resolution, WHO will develop a draft global action plan to combat antimicrobial resistance, including antibiotic resistance for presentation to the World Health Assembly for approval next year.

Implementation of the International Health Regulations (2005)

Yellow fever is a disease specified in the International Health Regulations (2005) for which countries may require proof of vaccination from travellers as a condition of entry under certain circumstances, and may take certain measures if an arriving traveller does not have this certificate in his possession.

The Health Assembly adopted revised provisions on yellow fever vaccination or revaccination under the International Health Regulations (2005). These include extending the validity of a certificate of vaccination against yellow fever from 10 years to the extent of the life of the vaccinated person. The revised provisions are based on the recommendations of the Strategic Advisory Group of Experts (SAGE) on immunization following its scientific review and analysis of evidence.

Member States reaffirmed their strong and continuous commitment to the implementation of International Health Regulations (2005).

Public health impacts of exposure to mercury and mercury compounds: the role of WHO and ministries of public health in the implementation of the Minamata Convention

The World Health Assembly requested the WHO Secretariat provide expert advice to help health ministries implement the Minamata Convention on Mercury. Most mercury is released as a result of human activity, such as burning coal and waste and mining for mercury, gold and other metals. WHO considers mercury one of the top ten chemicals or groups of chemicals of major public health concern.

The 2013 Minamata Convention aims to “protect human health and the environment from anthropogenic emissions and releases of mercury and mercury compounds”. The legally binding convention will enter into force when 50 countries have ratified it. It encourages countries to identify and better protect people who are at particular risk from mercury and highlights the need to provide effective health services for everyone who has been affected by exposed to mercury.

Addressing the global challenge of violence, in particular against women and girls

Across the world, each year, nearly 1.4 million people lose their lives to violence. Women and girls experience specific forms of violence that are often hidden. Globally, 1 in 3 women experience physical and/or sexual violence at least once in her life. For every person who dies as a result of violence, many more are injured and suffer from a range of adverse physical and mental health outcomes.

Member States will work to strengthen the role of the health system in addressing violence. WHO will develop a global plan of action to strengthen the role of national health systems within a multi-sectoral response to address interpersonal violence, in particular against women and girls, and against children.

Follow up of the Recife Political Declaration on Human Resources for Health: renewed commitments towards universal health coverage

The Recife Political Declaration was formulated and adopted by participants of the Third Global Forum on Human Resources for Health, in November 2013. Rooted in the right to health approach, the Recife Declaration recognizes the centrality of human resources for health in the drive towards universal health coverage. It commits governments to creating the conditions for the inclusive development of a shared vision with other stakeholders and reaffirms the role of the WHO Global Code of Practice on the International Recruitment of Health Personnel as a guide for action to strengthen the health workforce and health systems.

Follow-up of the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination

The Heath Assembly approved a resolution that significantly advances the quest for innovative, sustainable solutions for financing and coordinating health research and development (R&D) for diseases that disproportionately affect developing countries. The decision provides a firm go-ahead on the implementation of innovative health R&D demonstration projects.

By virtue of this decision, WHO will take the first steps to establish at the Special Programme for Research and Training in Tropical Diseases (TDR) a pooled fund for voluntary contributions towards R&D for diseases of the poor. WHO Member States have emphasised the importance of inclusive coordination of these new developments.

Access to essential medicines

WHO’s strategy to help countries improve access to essential medicines was approved. Key principles include selecting a limited range of medicines on the basis of the best evidence available, efficient procurement, affordable prices, effective distribution systems, and rational use. The WHO Essential medicines list was recognized as a valuable tool that enables countries to identify a core set of medicines which need to be available to provide quality medical care.

Regulatory system strengthening

Effective medicines regulation ensures that medicines and medical products are of the required quality, safety and efficacy; medicines are appropriately manufactured, stored, distributed and dispensed; illegal manufacturing and trade is controlled and prevented; health professionals and patients have the necessary information to enable them to use medicines rationally; promotion and advertising is regulated and fair; and access to medicines is not hindered by unjustified regulatory work.

In order to improve the regulation of medical products globally and ensure that medical products are of assured quality, more emphasis needs to be placed on regulatory strengthening, and promoting collaboration in regulatory systems.

The WHA mandated WHO, in cooperation with national regulators, to continue its important role globally in medicines regulation through establishing necessary norms and standards, supporting regulatory capacity-building and strengthening safety monitoring programmes. Through its Prequalification programme, WHO is requested to continue to ensures the quality, safety and efficacy of selected priority essential medicines, diagnostics and vaccines. A new development endorsed by Member States is the future progressive transition of prequalification to networks of strengthened regulatory authorities.

Health intervention and technology assessment in support of universal health coverage

Many countries currently lack the capacity to assess the merits of health technology. Health technology assessment (HTA) involves systematically evaluating the properties, effects, and/or impacts of different health technologies. Its main purpose is to inform technology-related policy-making in health care, and thus improve the uptake of cost-effective new technologies and prevent the uptake of technologies that are of doubtful value for the health system. Wasteful spending on medicines and other technologies has been identified as a major cause of inefficiencies in health service delivery.

Following the adoption of a resolution on HTA at the Health Assembly, WHO will support capacity-building for health technology assessment in countries. It will provide tools and guidance to prioritize health technologies and intensify networking and information exchange among countries to support priority setting.

Health in the post-2015 development agenda

Member States approved a resolution on health in the post-2015 development agenda, stressing the need for ongoing engagement in the process of setting the agenda. This includes a need to complete the unfinished work of the health Millennium Development Goals, newborn health, as well as an increased focus on noncommunicable diseases, mental health and neglected tropical diseases. The resolution also stresses the importance of universal health coverage and the need to strengthen health systems.

Accountability through regular assessment of progress by strengthening civil registration, vital statistics and health information systems are crucial. Member States emphasized the importance of having health at the core of the post-2015 development agenda.

Newborn health: draft action plan

The first-ever global plan to end preventable newborn deaths and stillbirths by 2035 calls for all countries to aim for fewer than 10 newborn deaths per 1000 live births and less than 10 stillbirths per 1000 total births by 2035.

Every year almost 3 million babies die in the first month of life and 2.6 million babies are stillborn (die in the last 3 months of pregnancy or during childbirth). Most of these deaths could be prevented by cost-effective interventions.

The Plan’s goals will require every country to invest in high-quality care before, during and after childbirth for every pregnant woman and newborn and highlights the urgent need to record all births and deaths.

FDA officials say they’re ‘serious’ about pharma’s free speech

23 May, 2014

reference: http://www.pharm.org.tw/pstplatform/en/?p=5331

Spouce: Fiercepharma

FDA officials are having a rethink on free speech–and that could end with an about-face on off-label marketing.

What with key court decisions apparently backing First Amendment protections for drug promotions, the FDA has moved off-label communications to the top of its to-do list, officials said at a recent FDA law conference. And off-label marketing is a hot-button issue, what with the series of multibillion-dollar settlements with the U.S. Justice Department…

Read more: FDA officials say they’re ‘serious’ about pharma’s free speech – FiercePharma http://www.fiercepharma.com/story/fda-officials-say-theyre-serious-about-pharmas-free-speech/2014-05-21#ixzz32VMXSoTv

Evidence growing for pharmacists’ positive impact on outcomes

23 May, 2014

reference: http://www.pharm.org.tw/pstplatform/en/?p=5343

Source: American Pharmacists Association

Avalere Health releases independent report today
The evidence around pharmacists’ impact on improving clinical and economic outcomes is growing, but continued research may help to further inform policy makers and health care providers, Avalere Health concluded in an independent report, Exploring Pharmacists’ Role in a Changing Health Care Environment.

Read more: http://www.pharmacist.com/evidence-growing-pharmacists-positive-impact-outcomes

iBulletin140523

23 May, 2014

reference: http://www.mps.org.my/newsmaster.cfm?&menuid=37&action=view&retrieveid=3897

MESSAGE FROM THE PRESIDENT

Dear Members,

Welcome to the capital city, Kuala Lumpur!

We thank the members and Pharmacists who spare the time to attend the 47th MPS Seminar 2014 and Annual Dinner. The theme of the Seminar is on the important topics of “Medication Safety – The Pharmacist Concern and Challenges of Pharmacy”. Several papers will be presented by both foreign and local notable speakers. All the topics are interesting and relevant for Pharmacy Practice.

On Sunday, there will be several sessions concerning a wide range of topics. Of special mention is a panel discussion on the “Issues on Pharmaceutical Pricing Discrimination”. This promises to provide an insight into the situation as the distinguished speakers share their experiences. In the afternoon, there will be another high-powered Panel Discussion on “Dispensing Separation Strategies”. Much ground work has been done on these two special panel discussion and we look forward to the lively discussion.

The 47th Annual Dinner will provide a time for guests for relax and interact with each other over the dinner tables. The theme of the Evening is “Asian Fest“ and guests are requested to don traditional costumes of Asia and let their hair down. This is specially designed as we gear-up to attend the 25th Federation of Asian Pharmaceutical Associations (FAPA) Congress 2014 from 9 – 12 October 2014. The early bird registration for the Congress at Malaysian Ringgit RM1,050.00 will close by 31-5-2014. Hence, please put pen to paper and register on line to avoid disappointment.

The highlight of this weekend will be the 47th Annual General Meeting when members will gather to receive the Report Cards of the Council and its various areas committees and Chapters. An election will be held where 14 Council Members will be elected into office. The Malaysian Pharmaceutical Society has grown thanks to the support of many members out there. The kitty has become stronger and the Malaysian Pharmaceutical Society can look forward to better times ahead. We are proud of our members working hard and excelling in different arenas. Let us continue to enhance each other with mutual-respect and look positively to build a stronger Society.

Thank you for doing us proud and we continue to look to the future with enthusiasm and hope. May the positive energy empower us to construct a bigger and stronger Society.

Yours in MPS

(Datuk Nancy Ho)
President

MPS AGM 2014

If you have not yet cast your vote to bring in the team of Council Members for the next term, tomorrow is the last day to do so. But do not post it anymore as it will not be received in time.  Instead you have to come to the venue of the AGM tomorrow (Grand Mahkota Ballroom, Hotel Istana, Kuala Lumpur) to drop your sealed envelope at the Ballot box by 2.30pm before the announcement to close the balloting.

Just a reminder that the MPS 47th Annual General Meeting shall take place on24th May 2014 at 2.30pm in Hotel Istana, Kuala Lumpur. All members are invited to attend.

While voting for next council members, please take note the advice from MPS Honorary General Legal Advisor

ADVICE FROM THE MPS HONORARY GENERAL LEGAL ADVISOR:

The 47th Annual General Meeting is scheduled to be held on 24th May 2014. As General Legal Counsel of the Society, I am certain that all meeting procedures will be conducted in an orderly manner as befitting a Professional Body. As A Body that is 47th years old, it has seen much growth in membership strength and quality of members. An Annual General Meeting will be an opportunity for members to receive the Report Card of the Council and to elect the new Council. I’m made to understand that many nominations have been received vying the 14 posts in the Council. The Ballot papers have been sent out for members to cast their votes until 5pm on 22nd May 2014. Vote wisely because Malaysian Pharmaceutical Society is made up of members who are well-respected and the incoming Council members will need to lead the Society to the next level of growth. All those who offer to serve in the Council must be appreciated by members who will accord them their utmost support. Kindly have a good healthy democratic election and voting should be done without casting any unhealthy remarks on any candidate or member nominated in any form of media in order for all members to vote with utmost professional decorum.

Wish all the best to all the candidates standing for the election.

Yours faithfully,

Dato’ Dr Manjit Singh Sachdev.

General Legal Counsel

>>> Link to original document

IMPORTANT ANNOUNCEMENT: WELCOME TO THE FORUM DURING MPS ANNUAL SEMINAR

Please note that on 25th May 2014, there will be 2 Forum on Challenges for Pharmacy.

Forum
Issues on Pharmaceutical Pricing 
Discrimination
 
Forum
Dispensing Separation Implementation 
Strategies
 
Here members are strongly advised to come prepared to give their views as well as TO PROVIDE CONSTRUCTIVE SUGGESTIONS to overcome the issue
 
A 14-point strategy will be presented for discussion and feedback. Do come to give your views
Date: 25th May 2014
Time: 11.00am – 1.00pm
Venue: Mahkota Ballroom, Hotel Istana, Kuala Lumpur
 
Date: 25th May 2014
Time: 2pm – 4pm
Venue: Mahkota Ballroom, Hotel Istana, Kuala Lumpur
  The objective is to achieve dispensing separation in tandem with the implementation of GST with a target date of 1st April 2015

If you have not yet register, you may do so on-site.

MPS ANNUAL SEMINAR 2014

The Annual Seminar will start this afternoon with topics on therapeutic guidelines.

Tomorrow topic highlight will be on Medication Safety with specially invited speakers from the US, Saudi Arabia, a dedicated advocate of Social Pharmacy from USM, and also a Director of Hospital

For Sunday the focus will be on Challenges for Pharmacy with 2 Forum for feedback for Pricing as well as Dispensing Separation.

The soon-to-be-introduced BLESS will be showcase for the first time to the participants attending the Seminar.

MPS IS HIRING – HEAD OF CPD

Malaysian Pharmaceutical Societyis the only professional Society for the Pharmacists. Delivering Continuing Professional Development (CPD), in an appropriate and timely manner, to members is one of the important roles of the Society.

CPD encompasses participation by members through web-learning, workshops, congresses, seminars or contribution towards pharmacy education and development by delivering lectures to professional bodies, trade associations or public.

We are inviting qualified candidate to be the Head of CPD Program. Attractive remuneration and benefits will be offered to the right candidate.

>>> For more information of the position and application

VACANCIES

  • Production Pharmacist and R&D Pharmacist/ Terengganu/ Xorix Sdn Bhd/  hr@xorix.com.my
  • Retail Pharmacists/ Bangi, KLIA2, Bandar Baru Salak Tinggi/ Kell:  013-3333673, Firdaus:  013-3333663/  kellsweetie84@gmail.com
  • Pharmacist/ Penang/ Penang Adventist Hospital/  hrd@pah.com.my
  • Assistant or Associate Professor/ School of Pharmacy, University of Nottingham/ Pn Salma Abd Kadir: 03-89248201/  salma.abdkadir@nottingham.edu.my
  • Retail Pharmacists or Business Partners needed/ Klang Valley/ Axiana Pharmacy/ Mr. Chin: 017-3325855/  kimlin.chin@gmail.com
  • Retail Pharmacist/ Farmasi Goodmedic/ Mr. Siah: 03-91333395, 012-3388152
  • Retail Pharmacist/ Johor Bahru, Johor/ IJ Pharmacy (M) Sdn Bhd/ Ms Chang:  07-3552878
  • Retail Pharmacist/ Klang, Petaling Jaya & Shah Alam/ Mr Vinaybalaji:  014-2273072/  vinaybalaji1975@gmail.com
  • Retail Pharmacist/ Ampang/ Farmasi Ampang/ Winston Chiu:  012-2073788/  chiu.winston@gmail.com
  • Retail Pharmacist/ Klang Valley/ Constant Pharmacy/ Mr Loh –  loh@constant.com.my
  • Retail Pharmacist/ Batu Pahat, Yong Peng, Muar, Parit Raja, & Rengit/ Farmasi Murni Marketing Sdn. Bhd. / Mr. Liew: 012-7777023/  jeromeliew@murni2u.com
  • Retail Pharmacist/ Melaka/ Home-Care Pharmacy Sdn Bhd/ Mr. Koo: 0126838633 @ 0162368110/  anthonyfoong@hcarepharmacy.com
  • Retail Pharmacist/ Klang Valley/ Materia Medica Pharmacy/ Mr Saiful Islam Yusoff : 013 628 0139/ Pn Puteri Nurulain Salleh: 03 6038 1810/  sainukahabib@ymail.com
  • Production Pharmacist/ Melaka/ Xepa-Soul Pattinson (M) Sdn Bhd/ Human Resource Department: 06-3351515/  jobs@xepasp.com
  • Retail Pharmacist/ Ipoh/ Globe Pharmacy/ Mr. Rajiv: 016-2603444, Mr. Sim: 012-5576812/  hr.globepharmacy@gmail.com
  • Clinical Informaticist (Pharmacy)/ Kuala Lumpur/ Pantai Holdings BHD/  yow.huaimim@pantai.com.my
  • Pharmacist/ Petaling Jaya, Selangor/ Tropicana Medical Centre (M) Sdn Bhd/ Mr Shazli Sallehudin: 603-62871196/  shazlis@tmclife.com
  • Retail Pharmacist/ Watson’s Personal Care Stores Sdn Bhd/ HR Department: 03-21432386/  careers@watsons.com.my 

 

iBulletin140517

17 May, 2014

reference: http://www.mps.org.my/newsmaster.cfm?&menuid=37&action=view&retrieveid=3895

MPS ANNUAL SEMINAR AND AGM 2014

This year MPS Annual Seminar is set to be another record, not only in terms of the number of participants but also on the lecture topics, speakers and exhibition booths and as well for the Conference dinner.

The topic on Medication Safety with specially invited speakers from the US, Saudi Arabia, a dedicated advocate of Social Pharmacy from USM, and also a Director of Hospital all adds up to give a program not to be missed. 

There are also topics on therapeutics guidelines as well as a topic on the understanding of generic  assurance program as well as a topic on CPG Guideline.

An equally not-to-be-missed program will be one on the Forum on Community Pharmacy Issues.  Good Dispensing Practice is presented as well as a review of legislation affecting community pharmacy.  The soon-to-be-introduced BLESS will be showcase for the first time to the participants attending the seminar and a special exhibition booth is allocated to this project for hands-on experience.

What may possibly be the top of all the program is Panel Discussion on Issues on Pharmaceutical Pricing Discrimination. Here members are strongly advised to come prepared to give their views as well as TO PROVIDE CONSTRUCTIVE SUGGESTIONS to overcome the issue.

A close-to-the-heart topic of all pharmacists is the dispensing separation and an afternoon session is dedicated to it to discuss on strategies.

Another possibly THE top of the weekend program will be the MPS AGM and biennale Election where members will have the opportunity to chose the next set of council members, or chose to re-elect the present council for another term of office. This is happening on 24th May from 2.30pm

Do not be miss out. Registration is still open even though the number of registered participants now is beyond 500.  The hotel chosen is able to accommodate all of you who are willing to spend the 3 days from 23rd – 25th May with the MPS.

MPS AGM : 24TH MAY 2014

This is a reminder that the MPS 47th Annual General Meeting shall take place on24th May 2014 at 2.30pm in Hotel Istana, Kuala Lumpur. All members are invited to attend.

This is an election year and 14 council members are due for election.  Do not forget to send in your ballot paper to vote for your council member for the next term, be it a new set, or re-election of existing council. There are a total of 20 candidates vying for the 14 seats.  Out of the 20, there are 10 new faces who would like to come forward to shoulder the responsibility to bring the Society forward for the next 2 years.  So support your candidate with your votes.

While we are voting for next council members, please take note the advice from MPS Honorary General Legal Advisor

Election of Malaysian Pharmaceutical Society

The 47th Annual General Meeting is scheduled to be held on 24th May 2014. As General Legal Counsel of the Society, I am certain that all meeting procedures will be conducted in an orderly manner as befitting a Professional Body. As A Body that is 47th years old, it has seen much growth in membership strength and quality of members. An Annual General Meeting will be an opportunity for members to receive the Report Card of the Council and to elect the new Council. I’m made to understand that many nominations have been received vying the 14 posts in the Council. The Ballot papers have been sent out for members to cast their votes until 5pm on 22nd May 2014. Vote wisely because Malaysian Pharmaceutical Society is made up of members who are well-respected and the incoming Council members will need to lead the Society to the next level of growth. All those who offer to serve in the Council must be appreciated by members who will accord them their utmost support. Kindly have a good healthy democratic election and voting should be done without casting any unhealthy remarks on any candidate or member nominated in any form of media in order for all members to vote with utmost professional decorum.

Wish all the best to all the candidates standing for the election.

Yours faithfully,

Dato’ Dr Manjit Singh Sachdev.

General Legal Counsel

>>> Link to original document

MPS IS HIRING – HEAD OF CPD

Malaysian Pharmaceutical Societyis the only professional Society for the Pharmacists. Delivering Continuing Professional Development (CPD), in an appropriate and timely manner, to members is one of the important roles of the Society.

CPD encompasses participation by members through web-learning, workshops, congresses, seminars or contribution towards pharmacy education and development by delivering lectures to professional bodies, trade associations or public.

We are inviting qualified candidate to be the Head of CPD Program. Attractive remuneration and benefits will be offered to the right candidate.

>>> For more information of the position and application

GOOD PHARMACY PRACTICE (GPP) INTERNATIONAL TRAINING PROGRAMME TRAVEL GRANT SCHOLARSHIP

The Pharmaceutical Society of Taiwan is offering Travel Scholarship for cutting edge international Good Pharmacy Practice (GPP) Training Programme for pharmacists around Asia. The aim is to strengthen international collaboration, and share own experience in pursuing higher standard of quality pharmaceutical services among Asian colleagues.

The pharmacists targeted are those from professional pharmacy organizations, especially from developing countries as listed in this document below.

Travel Grant Scholarships will reimburse each awardee’s full round-trip airfare. The total travel grant for each awardee is counted as USD$1,000 at least.

For detail information, please like to:  http://apro.ipsf.org/gpped (different registration pathway)

Timeline: The application deadline is set on May 23th (Friday). The announcing of selected awardees is schedule on May 26rd (Friday).

The applicant should apply on-line no later than May 23rd and the online application site is  http://goo.gl/YkHdFa

>>> For more information

VACANCIES

  • Pharmacist/ Penang/ Penang Adventist Hospital/  hrd@pah.com.my
  • Assistant or Associate Professor/ School of Pharmacy, University of Nottingham/ Pn Salma Abd Kadir: 03-89248201/  salma.abdkadir@nottingham.edu.my
  • Retail Pharmacists or Business Partners needed/ Klang Valley/ Axiana Pharmacy/ Mr. Chin: 017-3325855/  kimlin.chin@gmail.com
  • Retail Pharmacist/ Farmasi Goodmedic/ Mr. Siah: 03-91333395, 012-3388152
  • Retail Pharmacist/ Johor Bahru, Johor/ IJ Pharmacy (M) Sdn Bhd/ Ms Chang:  07-3552878
  • Retail Pharmacist/ Klang, Petaling Jaya & Shah Alam/ Mr Vinaybalaji:  014-2273072/  vinaybalaji1975@gmail.com
  • Retail Pharmacist/ Ampang/ Farmasi Ampang/ Winston Chiu:  012-2073788/  chiu.winston@gmail.com
  • Retail Pharmacist/ Klang Valley/ Constant Pharmacy/ Mr Loh –  loh@constant.com.my
  • Retail Pharmacist/ Batu Pahat, Yong Peng, Muar, Parit Raja, & Rengit/ Farmasi Murni Marketing Sdn. Bhd. / Mr. Liew: 012-7777023/  jeromeliew@murni2u.com
  • Retail Pharmacist/ Melaka/ Home-Care Pharmacy Sdn Bhd/ Mr. Koo: 0126838633 @ 0162368110/  anthonyfoong@hcarepharmacy.com
  • Retail Pharmacist/ Klang Valley/ Materia Medica Pharmacy/ Mr Saiful Islam Yusoff : 013 628 0139/ Pn Puteri Nurulain Salleh: 03 6038 1810/  sainukahabib@ymail.com
  • Production Pharmacist/ Melaka/ Xepa-Soul Pattinson (M) Sdn Bhd/ Human Resource Department: 06-3351515/  jobs@xepasp.com
  • Retail Pharmacist/ Ipoh/ Globe Pharmacy/ Mr. Rajiv: 016-2603444, Mr. Sim: 012-5576812/  hr.globepharmacy@gmail.com
  • Clinical Informaticist (Pharmacy)/ Kuala Lumpur/ Pantai Holdings BHD/  yow.huaimim@pantai.com.my
  • Pharmacist/ Petaling Jaya, Selangor/ Tropicana Medical Centre (M) Sdn Bhd/ Mr Shazli Sallehudin: 603-62871196/  shazlis@tmclife.com
  • Retail Pharmacist/ Watson’s Personal Care Stores Sdn Bhd/ HR Department: 03-21432386/  careers@watsons.com.my

 

iBulletin140508

08 May, 2014

reference: http://www.mps.org.my/newsmaster.cfm?&menuid=37&action=view&retrieveid=3894

MPS COUNCIL ELECTIONS 2014

At the close of the nomination for Council Member election, there were a total of 20 candidates vying for the 14 seats for the term 2014/2016. There are 10 new candidates for this election, with another 10 of the present council seeking re-election. 

The full list of the candidates can be found at 

>>> The full list of candidates can be found online here, as well as their CV

It seems more community pharmacy are coming forward to be represented at the council as 11 nominations are from the community sector.  The government pharmacists has 3 candidates, whereas academia and industry has 2 each, and private hospital and consultant 1 each. 

Please note that the online Ballot Paper is not valid for voting.

The official original Ballot Paper has been sent out to members by post and the MPS Secretariat is already receiving back the ballot.

Members are advised to mark the candidates of their choice in the ballot paper carefully within the box.

The ballot paper must be received by the MPS Secretariat by 5.00pm on 22nd May 2014, but you may also cast your vote personally using the ballot paper that you received by post, at the AGM. No ballot paper will be issue to anyone at the AGM. 

ADVICE AND COMMENTS FROM THE MPS HONORARY GENERAL LEGAL ADVISOR

Election of Malaysian Pharmaceutical Society

The 47th Annual General Meeting is scheduled to be held on 24th May 2014. As General Legal Counsel of the Society, I am certain that all meeting procedures will be conducted in an orderly manner as befitting a Professional Body. As A Body that is 47th years old, it has seen much growth in membership strength and quality of members. An Annual General Meeting will be an opportunity for members to receive the Report Card of the Council and to elect the new Council. I’m made to understand that many nominations have been received vying the 14 posts in the Council. The Ballot papers have been sent out for members to cast their votes until 5pm on 22nd May 2014. Vote wisely because Malaysian Pharmaceutical Society is made up of members who are well-respected and the incoming Council members will need to lead the Society to the next level of growth. All those who offer to serve in the Council must be appreciated by members who will accord them their utmost support. Kindly have a good healthy democratic election and voting should be done without casting any unhealthy remarks on any candidate or member nominated in any form of media in order for all members to vote with utmost professional decorum.

Wish all the best to all the candidates standing for the election.

Yours faithfully,

Dato’ Dr Manjit Singh Sachdev

General Legal Counsel

>>> Download original document

GOOD PHARMACY PRACTICE (GPP) INTERNATIONAL TRAINING PROGRAMME TRAVEL GRANT SCHOLARSHIP

The Pharmaceutical Society of Taiwan is offering places to international pharmacists for the GPP Training program which will take place in July

The travel grantscholarships (max. up to 15 international pharmacists) is open till 23rd May

For more information please go direct to:
 http://l.facebook.com/l.php?u=http%3A%2F%2Fapro.ipsf.org%2Fgpped&h=RAQG9etoY&s=1
or
 http://l.facebook.com/l.php?u=http%3A%2F%2Fgoo.gl%2FYkHdFa&h=OAQGUiOhd&s=1]]

If you need furthur information please contact directly Mr Michael Wei-chih LIU, Pharmaceutical Society of Taiwan,  email:  Michael.L.taiwan@gmail.com

MALAYSIAN PHARMACEUTICAL INDUSTRY

A paper has been published in the Journal of Pharmaceutical Machinery and Engineering, Japan (28th Nov 2013).  It discussed briefly the Malaysia Healthcare System, the Malaysian Pharmaceutical Industry including some Healthcare National Key Economic Areas for Collaboration and Investment Opportunities.  Those who want a quick summary of such information may download the article here.

>>> Malaysia Pharmaceutical Industry – Collaboration and Investment Opportunities

SYMPOSIA SERIES ON PRIMARY CARE MEDICINE

The Manipal Alumni Association of Malaysia, is organising a Symposia Series on Primary Care Medicine on 21-22 June in Le Meridien, KL. 

The expected topics include usage of Aspirin, choice of T2D Treatment, Sore Throat treatment, and also a symposium on New Concepts and Practices in Advanced Would Care Management.

Through a mutual arrangement MPS members fees shall be RM100/- only. In addition, there will be a 10+ 1 free registration offer but this must be register directly with the organiser, ie you need to get together in groups of 11.

>>> Downloa flyer

VACANCIES

  • Retail Pharmacist/ Johor Bahru, Johor/ IJ Pharmacy (M) Sdn Bhd/ Ms Chang: 07-3552878
  • Retail Pharmacist/ Klang, Petaling Jaya & Shah Alam/ Mr Vinaybalaji: 014-2273072/  vinaybalaji1975@gmail.com
  • Retail Pharmacist/ Ampang/ Farmasi Ampang/ Winston Chiu: 012-2073788/  chiu.winston@gmail.com
  • Retail Pharmacist/ Klang Valley/ Constant Pharmacy/ Mr Loh –  loh@constant.com.my
  • Retail Pharmacist/ Batu Pahat, Yong Peng, Muar, Parit Raja, & Rengit/ Farmasi Murni Marketing Sdn. Bhd. / Mr. Liew: 012-7777023/  jeromeliew@murni2u.com
  • Retail Pharmacist/ Melaka/ Home-Care Pharmacy Sdn Bhd/ Mr. Koo: 0126838633 @ 0162368110/  anthonyfoong@hcarepharmacy.com
  • Retail Pharmacist/ Klang Valley/ Materia Medica Pharmacy/ Mr Saiful Islam Yusoff : 013 628 0139/ Pn Puteri Nurulain Salleh: 03 6038 1810/  sainukahabib@ymail.com
  • Production Pharmacist/ Melaka/ Xepa-Soul Pattinson (M) Sdn Bhd/ Human Resource Department: 06-3351515/  jobs@xepasp.com
  • Retail Pharmacist/ Ipoh/ Globe Pharmacy/ Mr. Rajiv: 016-2603444, Mr. Sim: 012-5576812/  hr.globepharmacy@gmail.com
  • Clinical Informaticist (Pharmacy)/ Kuala Lumpur/ Pantai Holdings BHD/  yow.huaimim@pantai.com.my
  • Pharmacist/ Petaling Jaya, Selangor/ Tropicana Medical Centre (M) Sdn Bhd/ Mr Shazli Sallehudin: 603-62871196/  shazlis@tmclife.com
  • Retail Pharmacist/ Watson’s Personal Care Stores Sdn Bhd/ HR Department: 03-21432386/  careers@watsons.com.my
  • Retail Pharmacist/ Ampang Area, Desa Petaling, Kepong Area, Klang, Kota Kemuning, Mutiara Tropicana, Puchong, Setia Alam, Sungai Buloh, Sri Damansara, Setiawangsa, Sentul, Setapak area, Selangor Mansion , Selayang, Sri Rampai & Taman Melawati/ Health Lane Family Pharmacy/  hr@healthlane.com.my 
  • Pharmacist (Rengit-Johor)/ Pharmacist & experienced Pharmacist Assistances (Parit Sulong-Johor)/ Pharmacist (Kota Kinabalu-Sabah)/ Kinabalu Pharmacy (Batu Pahat) Sdn Bhd/ Mr Lim: 07-434043/  kpsb02@gmail.com

– See more at: http://www.mps.org.my/newsmaster.cfm?&menuid=37&action=view&retrieveid=3894#sthash.44TAVTBh.dpuf

iBulletin 140502

02 May, 2014

reference: http://www.mps.org.my/newsmaster.cfm?&menuid=37&action=view&retrieveid=3892

MESSAGE FROM THE PRESIDENT

Warm Greetings To All,

The warmth of our greetings come even stronger after the warm welcome received during a whirlwind visit to the Philippines to attend the National Convention of the Philippines Pharmacists’ Association in Davao. The main purpose of the visit was to promote the 25th FAPA Congress 2014. I was joined by the Honorary Treasurer Andrew Tan and Executive Director Lam Kai Kun. All three of us were impressed by the unity and solidarity shown during the Convention. The three day Convention was attended by 2560 pharmacists from all over the Country. The exhibition booths were well patronized, the biggest being from Unilabs. The Opening Ceremony was officiated by the National President Mrs Leonila Ocampo. For this Convention, 15 CPD was awarded to delegates but they not only have to attend every sessions, but they have to be attentive, otherwise they will be penalized 5 points at a time for inattentiveness. Very interesting condition to earn the CPD points!


 

 

Pharmacists, we look forward to welcome you at 25th FAPA Congress 2014 from 9th to 12th October 2014 in Kota Kinabalu, Sabah. Every effort is made to ensure that you benefit from the Congress. There shall be 20 CPD points awarded to delegates. The deadline for early bird has been extended to 31-5-2014.

The registration fee for early birds is RM1, 050.00. This amount is very reasonable for an International Congress. What’s more it is held in our own Country.

On another note, the 47th MPS Seminar 2014 held from 23 – 25 May 2014 at Hotel Istana, Kuala Lumpur promises to be an rewarding event. The topic “Medication Safety – The Pharmacist’s Concern and Challenges for Pharmacy” is relevant as we explore the many issues facing Pharmacists today. Short, medium and long term strategies will also be explored. We look forward to a good turnout. There will also be a special forum for pharmacists to discuss challenges. Please read announcement on the forum. There will be 14 CPD Points awarded for the Seminar.

The Annual General Meeting will be held on 24th May 2014 afternoon. 20 nominations have been received and members will cast their votes to elect leaders of The Malaysian Pharmaceutical Society who shall lead the Society forward. Each member is a leader and we believe that our Society has been blessed with members who are confident, competent, caring, committed and compassionate. Let us contrive to come forward to serve and make a difference.

Thank you for showing that you care. See you soon.

Yours in MPS

(Datuk Nancy Ho)
President

VACANCY

  • Retail Pharmacist/ Ampang/ Farmasi Ampang/ Winston Chiu: 012-2073788/ chiu.winston@gmail.com
  • Retail Pharmacist/ Klang Valley/ Constant Pharmacy/ Mr Loh – loh@constant.com.my
  • Retail Pharmacist/ Batu Pahat, Yong Peng, Muar, Parit Raja, & Rengit/ Farmasi Murni Marketing Sdn. Bhd. / Mr. Liew: 012-7777023/ jeromeliew@murni2u.com
  • Retail Pharmacist/ Melaka/ Home-Care Pharmacy Sdn Bhd/ Mr. Koo: 0126838633 @ 0162368110/ anthonyfoong@hcarepharmacy.com
  • Retail Pharmacist/ Klang Valley/ Materia Medica Pharmacy/ Mr Saiful Islam Yusoff : 013 628 0139/ Pn Puteri Nurulain Salleh: 03 6038 1810/ sainukahabib@ymail.com
  • Production Pharmacist/ Melaka/ Xepa-Soul Pattinson (M) Sdn Bhd/ Human Resource Department: 06-3351515/ jobs@xepasp.com
  • Retail Pharmacist/ Ipoh/ Globe Pharmacy/ Mr. Rajiv: 016-2603444, Mr. Sim: 012-5576812/ hr.globepharmacy@gmail.com
  • Clinical Informaticist (Pharmacy)/ Kuala Lumpur/ Pantai Holdings BHD/ yow.huaimim@pantai.com.my
  • Pharmacist/ Petaling Jaya, Selangor/ Tropicana Medical Centre (M) Sdn Bhd/ Mr Shazli Sallehudin: 603-62871196/ shazlis@tmclife.com
  • Retail Pharmacist/ Watson’s Personal Care Stores Sdn Bhd/ HR Department: 03-21432386/ careers@watsons.com.my
  • Retail Pharmacist/ Ampang Area, Desa Petaling, Kepong Area, Klang, Kota Kemuning, Mutiara Tropicana, Puchong, Setia Alam, Sungai Buloh, Sri Damansara, Setiawangsa, Sentul, Setapak area, Selangor Mansion , Selayang, Sri Rampai & Taman Melawati/ Health Lane Family Pharmacy/ hr@healthlane.com.my
  • Pharmacist (Rengit-Johor)/ Pharmacist & experienced Pharmacist Assistances (Parit Sulong-Johor)/ Pharmacist (Kota Kinabalu-Sabah)/ Kinabalu Pharmacy (Batu Pahat) Sdn Bhd/ Mr Lim: 07-434043/ kpsb02@gmail.com